Search

Your search keyword '"Baldacci S"' showing total 8 results
Start Over Author "Baldacci S" Journal annals of oncology
8 results on '"Baldacci S"'

2. 1341P NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes

Author

Dehem, A., primary, Mazieres, J., additional, Chour, A., additional, Guisier, F., additional, Ferreira, M., additional, Boussageon, M., additional, Girard, N., additional, Moro-Sibilot, D., additional, Cadranel, J., additional, Zalcman, G., additional, Ricordel, C., additional, Wislez, M., additional, Munck, C., additional, Poulet, C-H., additional, Gauvain, C., additional, Descarpentries, C., additional, Wasielewski, E., additional, Cortot, A.B., additional, and Baldacci, S., additional

Published
2021
Full Text
View/download PDF

3. 1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort

Author

Girard, N., primary, Girodet, S. Galland, additional, Duruisseaux, M., additional, Avrillon, V., additional, Roch, B., additional, Otto, J., additional, Cadranel, J., additional, Coudurier, M., additional, Moro-Sibilot, D., additional, Egenod, T., additional, Lamy, R., additional, Bennouna, J., additional, Zalcman, G., additional, Ricordel, C., additional, Tillon, J., additional, Odier, L., additional, Besse, B., additional, Missy, P., additional, Westeel, V., additional, and Baldacci, S., additional

Published
2020
Full Text
View/download PDF

4. 1303P Lorlatinib for advanced ALK+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort

Author

Baldacci, S., primary, Besse, B., additional, Avrillon, V., additional, Mennecier, B., additional, Dubray-Longeras, P., additional, Mazieres, J., additional, Descourt, R., additional, Duruisseaux, M., additional, Quantin, X., additional, Doubre, H., additional, Monnet, I., additional, Moro-Sibilot, D., additional, Schneider, S., additional, Cousin, S., additional, Merle, P., additional, Otto, J., additional, Langlais, A., additional, Morin, F., additional, Westeel, V., additional, and Girard, N., additional

Published
2020
Full Text
View/download PDF

6. Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort

Author

Domblides, C., primary, Monnet, I., additional, Mazieres, J., additional, Barlesi, F., additional, Gounant, V., additional, Baldacci, S., additional, Mennecier, B., additional, Toffart, A.C., additional, Audigier Valette, C., additional, Doucet, L., additional, Giroux-Leprieur, E., additional, Guisier, F., additional, Molinier, O., additional, Perol, M., additional, Pichon, E., additional, Robinet, G., additional, Templement Grangerat, D., additional, Ruppert, A.-M., additional, and Wislez, M., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results